{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:50:22Z","timestamp":1792839022234,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Jiangxi Provincial key Research and Development Plan","award":["812032173045"],"award-info":[{"award-number":["812032173045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To develop and validate an enhanced CT-based radiomics nomogram for evaluating preoperative metastasis risk of epithelial ovarian cancer (EOC). One hundred and nine patients with histologically confirmed EOC were retrospectively enrolled. The volume of interest (VOI) was delineated in preoperative enhanced CT images, and 851 radiomics features were extracted. The radiomics features were selected by the least absolute shrinkage and selection operator (LASSO), and the rad-score was calculated using the formula of the radiomics label. A clinical model, radiomics model, and combined model were constructed using the logistic regression classification algorithm. Receiver operating characteristic (ROC) curve analysis and decision curve analysis (DCA) were used to evaluate the diagnostic performance of the models. Seventy-five patients (68.8%) were histologically confirmed to have metastasis. Eleven optimal radiomics features were retained by the LASSO algorithm to develop the radiomic model. The combined model for evaluating metastasis of EOC achieved area under the curve (AUC) values of 0.929 (95% CI 0.8593\u20130.9996) in the training cohort and 0.909 (95% CI 0.7921\u20131.0000) in the test cohort. To facilitate clinical use, a radiomic nomogram was built by combining the clinical characteristics with rad-score. The DCA indicated that the nomogram had the most significant net benefit when the threshold probability exceeded 15%, surpassing the benefits of both the treat-all and treat-none strategies. Compared with clinical model and radiomics model, the radiomics nomogram has the best diagnostic performance in evaluating EOC metastasis. The nomogram is a useful and convenient tool for clinical doctors to develop personalized treatment plans for EOC patients.<\/jats:p>","DOI":"10.1038\/s41598-024-63369-1","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T13:02:47Z","timestamp":1717074167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Yinping","family":"Leng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangxia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianggeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"issue":"6","key":"63369_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"63369_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66(2), 115\u2013132. https:\/\/doi.org\/10.3322\/caac.21338 (2016).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"63369_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3322\/caac.20113","volume":"61","author":"D Jelovac","year":"2011","unstructured":"Jelovac, D. & Armstrong, D. K. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J. Clin. 61(3), 183\u2013203. https:\/\/doi.org\/10.3322\/caac.20113 (2011).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"63369_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1172\/JCI65833","volume":"123","author":"RG Verhaak","year":"2013","unstructured":"Verhaak, R. G. et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J. Clin. Investig. 123(1), 517\u2013525. https:\/\/doi.org\/10.1172\/JCI65833 (2013).","journal-title":"J. Clin. Investig."},{"issue":"11","key":"63369_CR5","doi-asserted-by":"publisher","first-page":"8438","DOI":"10.1007\/s00330-021-08004-7","volume":"31","author":"XL Song","year":"2021","unstructured":"Song, X. L. et al. Radiomics based on multisequence magnetic resonance imaging for the preoperative prediction of peritoneal metastasis in ovarian cancer. Eur. Radiol. 31(11), 8438\u20138446. https:\/\/doi.org\/10.1007\/s00330-021-08004-7 (2021).","journal-title":"Eur. Radiol."},{"key":"63369_CR6","doi-asserted-by":"publisher","first-page":"m3773","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki, L. & Guntupalli, S. R. Treatment of epithelial ovarian cancer. BMJ 371, m3773. https:\/\/doi.org\/10.1136\/bmj.m3773 (2020).","journal-title":"BMJ"},{"issue":"12","key":"63369_CR7","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/S1470-2045(18)30566-7","volume":"19","author":"I Vergote","year":"2018","unstructured":"Vergote, I. et al. Neoadjuvant chemo-therapy versus debulking surgery in advanced tubo-ovarian can-cers: Pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials. Lancet Oncol. 19(12), 1680\u20131687. https:\/\/doi.org\/10.1016\/S1470-2045(18)30566-7 (2018).","journal-title":"Lancet Oncol."},{"issue":"12","key":"63369_CR8","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s00330-006-0163-z","volume":"16","author":"M Bazot","year":"2006","unstructured":"Bazot, M. et al. MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology. Eur. Radiol. 16(12), 2687\u20132699. https:\/\/doi.org\/10.1007\/s00330-006-0163-z (2006).","journal-title":"Eur. Radiol."},{"issue":"2","key":"63369_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2214\/AJR.09.3522","volume":"194","author":"VR Iyer","year":"2010","unstructured":"Iyer, V. R. & Lee, S. I. MRI, CT, and PET\/CT for ovarian cancer detection and adnexal lesion characterization. Am. J. Roentgenol. 194(2), 311\u2013321. https:\/\/doi.org\/10.2214\/AJR.09.3522 (2010).","journal-title":"Am. J. Roentgenol."},{"issue":"5","key":"63369_CR10","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2214\/ajr.180.5.1801297","volume":"180","author":"SAA Sohaib","year":"2003","unstructured":"Sohaib, S. A. A. et al. Characterization of adnexal mass lesions on MR imaging. Am. J. Roentgenol. 180(5), 1297\u20131304. https:\/\/doi.org\/10.2214\/ajr.180.5.1801297 (2003).","journal-title":"Am. J. Roentgenol."},{"issue":"12","key":"63369_CR11","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00330-010-1886-4","volume":"20","author":"R Forstner","year":"2010","unstructured":"Forstner, R. et al. ESUR guidelines: Ovarian cancer staging and follow-up. Eur. Radiol. 20(12), 2773\u20132780. https:\/\/doi.org\/10.1007\/s00330-010-1886-4 (2010).","journal-title":"Eur. Radiol."},{"issue":"10","key":"63369_CR12","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3390\/diagnostics13101691","volume":"13","author":"M Hosseinzadeh","year":"2023","unstructured":"Hosseinzadeh, M. et al. Prediction of cognitive decline in Parkinson\u2019s disease using clinical and DAT SPECT imaging features, and hybrid machine learning systems. Diagnostics (Basel) 13(10), 1691. https:\/\/doi.org\/10.3390\/diagnostics13101691 (2023).","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"63369_CR13","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1007\/s00330-018-5802-7","volume":"29","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer. Eur. Radiol. 29(8), 4418\u20134426. https:\/\/doi.org\/10.1007\/s00330-018-5802-7 (2019).","journal-title":"Eur. Radiol."},{"issue":"14","key":"63369_CR14","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1088\/0031-9155\/60\/14\/5471","volume":"60","author":"M Valli\u00e8res","year":"2015","unstructured":"Valli\u00e8res, M., Freeman, C. R., Skamene, S. R. & El Naqa, I. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys. Med. Biol. 60(14), 5471\u20135496. https:\/\/doi.org\/10.1088\/0031-9155\/60\/14\/5471 (2015).","journal-title":"Phys. Med. Biol."},{"issue":"3","key":"63369_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1148\/radiol.2018180608","volume":"290","author":"K Drukker","year":"2019","unstructured":"Drukker, K. et al. Combined benefit of quantitative three-compartment breast image analysis and mammography radiomics in the classification of breast masses in a clinical data se. Radiology 290(3), 621\u2013628. https:\/\/doi.org\/10.1148\/radiol.2018180608 (2019).","journal-title":"Radiology"},{"issue":"1","key":"63369_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12880-023-01140-0","volume":"23","author":"H Khanfari","year":"2023","unstructured":"Khanfari, H. et al. Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI. BMC Med. Imaging 23(1), 195. https:\/\/doi.org\/10.1186\/s12880-023-01140-0 (2023).","journal-title":"BMC Med. Imaging"},{"issue":"2","key":"63369_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1148\/radiol.2019190357","volume":"293","author":"SA Mattonen","year":"2019","unstructured":"Mattonen, S. A. et al. Bone marrow and tumor radiomics at 18F-FDG PET\/CT: Impact on outcome prediction in non\u2013small cell lung cancer. Radiology 293(2), 451\u2013459. https:\/\/doi.org\/10.1148\/radiol.2019190357 (2019).","journal-title":"Radiology"},{"issue":"7","key":"63369_CR18","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1007\/s00330-019-06124-9","volume":"29","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: A preliminary study. Eur. Radiol. 29(7), 3358\u20133371. https:\/\/doi.org\/10.1007\/s00330-019-06124-9 (2019).","journal-title":"Eur. Radiol."},{"issue":"2","key":"63369_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1148\/radiol.2018181197","volume":"290","author":"HJ Park","year":"2019","unstructured":"Park, H. J. et al. Radiomics analysis of gadoxetic acid\u2013enhanced MRI for staging liver fibrosis. Radiology 290(2), 380\u2013387. https:\/\/doi.org\/10.1148\/radiol.2018181197 (2019).","journal-title":"Radiology"},{"key":"63369_CR20","doi-asserted-by":"publisher","first-page":"107714","DOI":"10.1016\/j.cmpb.2023.107714","volume":"240","author":"MR Salmanpour","year":"2023","unstructured":"Salmanpour, M. R. et al. Fusion-based tensor radiomics using reproducible features: Application to survival prediction in head and neck cancer. Comput. Methods Programs Biomed. 240, 107714. https:\/\/doi.org\/10.1016\/j.cmpb.2023.107714 (2023).","journal-title":"Comput. Methods Programs Biomed."},{"issue":"11","key":"63369_CR21","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.1007\/s00330-021-07962-2","volume":"31","author":"Q Xu","year":"2021","unstructured":"Xu, Q. et al. Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy. Eur. Radiol. 31(11), 8765\u20138774. https:\/\/doi.org\/10.1007\/s00330-021-07962-2 (2021).","journal-title":"Eur. Radiol."},{"key":"63369_CR22","doi-asserted-by":"publisher","first-page":"110018","DOI":"10.1016\/j.ejrad.2021.110018","volume":"145","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer. Eur. J. Radiol. 145, 110018\u2013110018. https:\/\/doi.org\/10.1016\/j.ejrad.2021.110018 (2021).","journal-title":"Eur. J. Radiol."},{"key":"63369_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat, J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int. J. Gynaecol. Obstet. 124, 1\u20135. https:\/\/doi.org\/10.1016\/j.ijgo.2013.10.001 (2014).","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"63369_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jnci\/djy071","volume":"111","author":"LC Peres","year":"2019","unstructured":"Peres, L. C. et al. Invasive epithelial ovarian cancer survival by histotype and disease stage. J. Natl. Cancer Inst. 111(1), 60\u201368. https:\/\/doi.org\/10.1093\/jnci\/djy071 (2019).","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"63369_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-016-0247-6","volume":"9","author":"F Morales-V\u00e1squez","year":"2016","unstructured":"Morales-V\u00e1squez, F. et al. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. J. Ovarian Res. 9(1), 1\u20136. https:\/\/doi.org\/10.1186\/s13048-016-0247-6 (2016).","journal-title":"J. Ovarian Res."},{"issue":"1","key":"63369_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/IGC.0000000000000586","volume":"26","author":"G S\u00f6l\u00e9tormos","year":"2016","unstructured":"S\u00f6l\u00e9tormos, G. et al. Clinical use of cancer biomarkers in epithelial ovarian cancer: Updated guidelines from the European Group on tumor markers. Int. J. Gynecol. Cancer 26(1), 43\u201351. https:\/\/doi.org\/10.1097\/IGC.0000000000000586 (2016).","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"6","key":"63369_CR27","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00259-017-3638-z","volume":"44","author":"B Khiewvan","year":"2017","unstructured":"Khiewvan, B. et al. An update on the role of PET\/CT and PET\/MRI in ovarian cancer. Eur. J. Nucl. Med. Mol. Imaging 44(6), 1079\u20131091. https:\/\/doi.org\/10.1007\/s00259-017-3638-z (2017).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"63369_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: Images are more than pictures, they are data. Radiology 278(2), 563\u2013577. https:\/\/doi.org\/10.1148\/radiol.2015151169 (2016).","journal-title":"Radiology"},{"issue":"9","key":"63369_CR29","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","volume":"30","author":"V Kumar","year":"2012","unstructured":"Kumar, V. et al. Radiomics: The process and the challenges. Magn. Reson. Imaging 30(9), 1234\u20131248. https:\/\/doi.org\/10.1016\/j.mri.2012.06.010 (2012).","journal-title":"Magn. Reson. Imaging"},{"key":"63369_CR30","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.3389\/fonc.2021.711648","volume":"11","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. The development and validation of a CT-based radiomics nomogram to preoperatively predict lymph node metastasis in high-grade serous ovarian cancer. Front. Oncol. 11, 3362. https:\/\/doi.org\/10.3389\/fonc.2021.711648 (2021).","journal-title":"Front. Oncol."},{"issue":"3","key":"63369_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiol.2018180910","volume":"290","author":"N Beig","year":"2019","unstructured":"Beig, N. et al. Perinodular and intranodular radiomic features on lung CT images distinguish adenocarcinomas from granulomas. Radiology 290(3), 783\u2013792. https:\/\/doi.org\/10.1148\/radiol.2018180910 (2019).","journal-title":"Radiology"},{"issue":"11","key":"63369_CR32","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1007\/s00330-018-5389-z","volume":"28","author":"S Rizzo","year":"2018","unstructured":"Rizzo, S. et al. Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months. Eur. Radiol. 28(11), 4849\u20134859. https:\/\/doi.org\/10.1007\/s00330-018-5389-z (2018).","journal-title":"Eur. Radiol."},{"issue":"1","key":"63369_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1148\/radiol.12112428","volume":"266","author":"B Ganeshan","year":"2013","unstructured":"Ganeshan, B. et al. Non\u2013small cell lung cancer: Histopathologic correlates for texture parameters at CT. Radiology 266(1), 326\u2013336. https:\/\/doi.org\/10.1148\/radiol.12112428 (2013).","journal-title":"Radiology"},{"issue":"1","key":"63369_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45312-x","volume":"9","author":"SA Nabavizadeh","year":"2019","unstructured":"Nabavizadeh, S. A. et al. Arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma. Sci. Rep. 9(1), 1\u20138. https:\/\/doi.org\/10.1038\/s41598-019-45312-x (2019).","journal-title":"Sci. Rep."},{"issue":"4","key":"63369_CR35","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jmri.26556","volume":"49","author":"RD Chitalia","year":"2019","unstructured":"Chitalia, R. D. & Kontos, D. Role of texture analysis in breast MRI as a cancer biomarker: A review. Magn. Reson. Imaging 49(4), 927\u2013938. https:\/\/doi.org\/10.1002\/jmri.26556 (2019).","journal-title":"Magn. Reson. Imaging"},{"issue":"1","key":"63369_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00330-018-5574-0","volume":"29","author":"BR Kim","year":"2019","unstructured":"Kim, B. R. et al. CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture anal-ysis. Eur. Radiol. 29(1), 362\u2013372. https:\/\/doi.org\/10.1007\/s00330-018-5574-0 (2019).","journal-title":"Eur. Radiol."},{"key":"63369_CR37","doi-asserted-by":"publisher","first-page":"711648","DOI":"10.3389\/fonc.2021.711648","volume":"11","author":"HZ Chen","year":"2021","unstructured":"Chen, H. Z. et al. The development and validation of a CT-based radiomics nomogram to preoperatively predict lymph node metastasis in high-grade serous ovarian cancer. Front. Oncol. 11, 711648. https:\/\/doi.org\/10.3389\/fonc.2021.711648 (2021).","journal-title":"Front. Oncol."},{"key":"63369_CR38","doi-asserted-by":"publisher","first-page":"610742","DOI":"10.3389\/fonc.2021.610742","volume":"11","author":"Y Ai","year":"2021","unstructured":"Ai, Y. et al. Preoperative prediction of metastasis for ovarian cancer based on computed tomography radiomics features and clinical factors. Front Oncol 11, 610742. https:\/\/doi.org\/10.3389\/fonc.2021.610742 (2021).","journal-title":"Front Oncol"},{"issue":"10","key":"63369_CR39","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.21037\/qims-22-115","volume":"12","author":"SM Rezaeijo","year":"2022","unstructured":"Rezaeijo, S. M. et al. Segmentation of the prostate, its zones, anterior fibromuscular stroma, and urethra on the MRIs and multimodality image fusion using U-Net model. Quant. Imaging Med. Surg. 12(10), 4786\u20134804. https:\/\/doi.org\/10.21037\/qims-22-115 (2022).","journal-title":"Quant. Imaging Med. Surg."},{"key":"63369_CR40","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.5114\/pjr.2023.130815","volume":"88","author":"S Heydarheydari","year":"2023","unstructured":"Heydarheydari, S., Birgani, M. J. T. & Rezaeijo, S. M. Auto-segmentation of head and neck tumors in positron emission tomography images using non-local means and morphological frameworks. Pol. J. Radiol. 88, e365\u2013e370. https:\/\/doi.org\/10.5114\/pjr.2023.130815 (2023).","journal-title":"Pol. J. Radiol."},{"issue":"14","key":"63369_CR41","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.3390\/cancers15143565","volume":"15","author":"SM Rezaeijo","year":"2023","unstructured":"Rezaeijo, S. M. et al. Within-modality synthesis and novel radiomic evaluation of brain MRI scans. Cancers (Basel) 15(14), 3565. https:\/\/doi.org\/10.3390\/cancers15143565 (2023).","journal-title":"Cancers (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63369-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63369-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63369-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T13:08:21Z","timestamp":1717074501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63369-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["63369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-63369-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Yu Wang reports a relationship with Clinical and Technical Support, Philips Healthcare, Shanghai, China that includes: employment. Other remaining authors has no conflict of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12456"}}